Current Report Filing (8-k)
May 15 2018 - 2:15PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
May 10, 2018
Nevada
|
000-55654
|
81-1118176
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer
Identification No.)
|
309 Celtic
Ct., Oviedo Florida
|
32765
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant’s Telephone Number, Including
Area Code
|
|
|
(Former name or former address, if changed since last report)
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2. below):
|_|
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|_|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|_|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
|_|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
Type: 8-K
Comme
nt/Description:
Item 2.02 Results of Operations and Financial Condition
On May 10, 2018, The Company has issued a Press Release announcing
that it has signed an exclusive 20-year, $90 million distribution agreement for its transdermal consumer product lines
with Best Choice Inc.
FOR THE FULL TERMS OF THE Press Release, PLEASE REFER TO THE COPY
THEREOF FILED AS EXHIBIT 99.2 TO THIS REPORT.
The company issued a Press Release on May10, 2018.
Item 8.01 Other Events.
DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS
Throughout this report, we make statements that may be deemed "forward-looking"
statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. All statements, other than statements of historical facts, that address activities, events, outcomes
and other matters that Chancellor plans, expects, intends, assumes, believes, budgets, predicts, forecasts, projects, estimates
or anticipates (and other similar expressions) will, should or may occur in the future are forward-looking statements. These forward-looking
statements are based on management's current belief, based on currently available information, as to the outcome and timing of
future events. When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements
in this report.
Any forward-looking statements that we may make are based
on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance
that future developments affecting us will be those anticipated by us. Any forward-looking statements are subject to the risks
and uncertainties that could cause actual results of operations, financial condition, cost reductions, acquisitions, dispositions,
financing transactions, operations, expansion, consolidation and other events to differ materially from those expressed or implied
in such forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements. As
a result, the reader is cautioned not to rely on these forward-looking statements. Due to known and unknown risks, the company’s
actual results may differ materially from its expectations or projections.
While most risks affect only future costs or revenues anticipated
by the company, some risks may relate to accruals that have already been reflected in results of operations. The company’s
failure to receive payments of accrued amounts or if liabilities are incurred in excess of amounts previously recognized, a charge
against future earnings could result. In addition, any forward-looking statements should be considered in context with various
disclosures made by us about our business including, without limitation, the risk factors more particularly described below in
“Risk Factors.”
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934,
THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.
|
|
|
|
Nutriband, INC.
|
|
|
|
Date: May 15, 2018
|
By:
|
/s/ Gareth Sheridan
|
|
R: Gareth Sheridan
|
|
Chief Executive Officer
|